Wells Fargo & Company MN boosted its position in shares of athenahealth, Inc (NASDAQ:ATHN) by 5.4% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 82,747 shares of the health services provider’s stock after buying an additional 4,243 shares during the quarter. Wells Fargo & Company MN owned 0.21% of athenahealth worth $11,009,000 at the end of the most recent quarter.
A number of other hedge funds have also recently made changes to their positions in ATHN. The Manufacturers Life Insurance Company boosted its stake in athenahealth by 7.7% during the second quarter. The Manufacturers Life Insurance Company now owns 1,179 shares of the health services provider’s stock valued at $166,000 after buying an additional 84 shares in the last quarter. Lakeview Capital Partners LLC bought a new position in athenahealth during the fourth quarter valued at about $295,000. Quantbot Technologies LP bought a new position in athenahealth during the third quarter valued at about $337,000. State of Alaska Department of Revenue bought a new position in athenahealth during the fourth quarter valued at about $385,000. Finally, SG Americas Securities LLC bought a new position in athenahealth during the third quarter valued at about $485,000.
Shares of athenahealth, Inc (ATHN) opened at $144.61 on Tuesday. The stock has a market capitalization of $5,733.98, a PE ratio of 84.61, a P/E/G ratio of 2.47 and a beta of 1.17. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.84 and a quick ratio of 1.84. athenahealth, Inc has a one year low of $95.01 and a one year high of $158.66.
athenahealth (NASDAQ:ATHN) last announced its quarterly earnings data on Thursday, February 1st. The health services provider reported $1.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.63 by $0.48. The firm had revenue of $329.20 million during the quarter, compared to the consensus estimate of $319.64 million. athenahealth had a return on equity of 9.21% and a net margin of 4.35%. The business’s revenue for the quarter was up 14.2% on a year-over-year basis. During the same period in the prior year, the business earned $0.62 EPS. analysts predict that athenahealth, Inc will post 2.69 earnings per share for the current year.
In related news, CEO Jonathan Bush sold 250 shares of the stock in a transaction dated Thursday, March 1st. The stock was sold at an average price of $139.27, for a total value of $34,817.50. Following the completion of the sale, the chief executive officer now directly owns 321,533 shares of the company’s stock, valued at approximately $44,779,900.91. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Amy Abernethy sold 500 shares of the company’s stock in a transaction dated Tuesday, December 26th. The stock was sold at an average price of $134.18, for a total value of $67,090.00. Following the completion of the transaction, the director now directly owns 4,045 shares in the company, valued at $542,758.10. The disclosure for this sale can be found here. Over the last three months, insiders sold 108,705 shares of company stock valued at $14,891,199. Company insiders own 3.20% of the company’s stock.
ATHN has been the subject of several research reports. BidaskClub raised athenahealth from a “strong sell” rating to a “sell” rating in a research note on Saturday, December 2nd. Deutsche Bank initiated coverage on athenahealth in a research note on Friday, December 8th. They set a “hold” rating and a $145.00 target price for the company. Citigroup initiated coverage on athenahealth in a research note on Thursday, January 4th. They set a “neutral” rating for the company. KeyCorp reaffirmed a “buy” rating and set a $152.00 target price on shares of athenahealth in a research note on Friday, January 12th. Finally, Evercore ISI initiated coverage on athenahealth in a report on Thursday, January 18th. They set an “in-line” rating and a $140.00 target price for the company. Three equities research analysts have rated the stock with a sell rating, seventeen have given a hold rating and seven have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average price target of $144.35.
ILLEGAL ACTIVITY NOTICE: This report was posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this report on another site, it was illegally stolen and republished in violation of United States and international trademark and copyright laws. The legal version of this report can be viewed at https://www.dispatchtribunal.com/2018/03/20/wells-fargo-company-mn-increases-position-in-athenahealth-inc-athn.html.
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.